Search Editorial Photos
"An employee checks the stock of medicines at a pharmacy in S..."
6 professional editorial images found
US President Donald Trump Slaps 100% Tariff On Branded Pharma Drug Imports
26 September 2025
#12798444
26 September 2025
An employee checks the stock of medicines at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company is building a manufacturing plant in the U.S.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
US President Donald Trump Slaps 100% Tariff On Branded Pharma Drug Imports
26 September 2025
#12798448
26 September 2025
An employee checks the stock of medicines at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company is building a manufacturing plant in the U.S.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
US President Donald Trump Slaps 100% Tariff On Branded Pharma Drug Imports
26 September 2025
#12798450
26 September 2025
An employee checks the stock of medicines at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company is building a manufacturing plant in the U.S.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
US President Donald Trump Slaps 100% Tariff On Branded Pharma Drug Imports
26 September 2025
#12798451
26 September 2025
An employee checks the stock of medicines at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company is building a manufacturing plant in the U.S.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
US President Donald Trump Slaps 100% Tariff On Branded Pharma Drug Imports
26 September 2025
#12798452
26 September 2025
An employee checks the stock of medicines at a pharmacy in Srinagar, Jammu and Kashmir, on September 26, 2025. US President Donald Trump says on Thursday that the United States imposes a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company is building a manufacturing plant in the U.S.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12625477
8 August 2025
An employee checks the stock of medicines at a pharmacy in Srinagar, Jammu and Kashmir, on August 8, 2025. President Donald Trump tells CNBC's ''Squawk Box'' on Tuesday that planned tariffs on pharmaceuticals imported into the U.S. could eventually reach up to 250%, the highest rate he threatens so far. Meanwhile, in an escalation of trade tensions between the United States and India, US President Donald Trump, on August 6, 2025, signs an executive order imposing a 25 percent ad valorem tariff on all Indian imports into the United States. The ad valorem duty imposed in Executive Order 14257 applies in addition to the ad valorem duty imposed in section 2 of the order. This effectively means some categories of Indian exports may face a combined tariff burden of over 50 percent, depending on their classification.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.